Search bioRxiv⌕ Search

Biology subjects

Sha, T.

Publications and source records attributed to Sha, T..

2 recordsLinked to original sources

PPARgene 2.0: leveraging large language models and multi-omics data for enhanced identification and prediction of PPAR target genes

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors of the nuclear receptor superfamily. Upon ligand binding, PPARs activate target gene transcription and regulate a variety of important physiological processes such as lipid metabolism, inflammation, wound healing and immune responses. PPARgene is a database that integrates literature-curated and computationally predicted PPAR target genes. It provides gene-level annotations including tissue specificity, species, and supporting PubMed IDs. Computational predictions are generated using a machine learning method that combines PPRE motif analysis with microarray expression data. Here, we introduce PPARgene 2.0, a 10-year update to the original PPARgene database. This update adds 35 newly reported PPAR target genes, 20 PPAR{beta}/{delta} target genes, and 72 PPAR{gamma} target genes, bringing the total number of curated target genes in the database to 337. To retrieve newly reported PPAR target genes from the literature, we used two language models to screen publications after 2016. Candidate papers were then manually reviewed, and verified target genes were added to the updated database. This update also improved the predictive method by expanding the volume of high-throughput gene expression data and incorporating PPAR-related ChIP-seq datasets alongside in silico PPRE analysis. Fivefold cross-validation demonstrated that the new predictive method outperforms the original one. The updated prediction tool is available as part of the PPARgene 2.0 platform. The database is openly accessible at https://www.ppargene.org.

bioinformatics↗

Isoliquiritigenin attenuated cognitive impairment, cerebral tau phosphorylation and oxidative stress in a streptozotocin-induced mouse model of Alzheimers disease

IntroductionTau hyperphosphorylation, mitochondrial dysfunction and oxidative stress play important roles in Alzheimers disease (AD). Isoliquiritigenin, a natural flavonoid isolated from the root of liquorice, has been shown to exert inhibitory effects on oxidative stress. Here, we assessed the neuroprotective effects of isoliquiritigenin on a streptozotocin-injected mouse model. MethodMolecular docking analysis performed for isoliquiritigenin with mTOR and ERK2. The mice (n = 27, male) were intracerebroventricularly injected with streptozotocin, treated with isoliquiritigenin (intraperitoneal, 2 days) and assessed using the Morris water maze. Oxidative stress, tau phosphorylation, mitochondrial dysfunction and synaptic impairment were evaluated in the cortex and hippocampal tissues of the mice by using biochemical assays and immunofluorescence staining. ResultsIsoliquiritigenin treatment mitigated the spatial memory capacity of streptozotocin-injected mice and alleviated tau phosphorylation at Ser396; the production of reactive oxygen species; the mitochondrial fission proteins Mfn1 and Mfn2; neuronal loss; and synaptic impairment (PSD95, SNAP25). Isoliquiritigenin treatment reduced the levels of mTOR Ser2448 and ERK1/2 T202/Y204 and upregulated the level of GSK-3{beta}Ser9 in the cortex and hippocampus of streptozotocin-injected mice. ConclusionIn conclusion, our findings suggest that isoliquiritigenin ameliorates streptozotocin-induced cognitive impairment, hyperphosphorylated tau, oxidative stress, mitochondrial dysfunction and synaptic impairment by decreasing mTOR and ERK activity and increasing GSK-3{beta} activity.

neuroscience↗